68 related articles for article (PubMed ID: 2143872)
21. Renal tubular cell expression of MHC class II (I-Eb) is insufficient to initiate immune injury in a transgenic kidney transplant model.
Jevnikar AM; Singer GG; Coffman T; Glimcher LH; Kelley VE
Transplant Proc; 1993 Feb; 25(1 Pt 1):142-3. PubMed ID: 8438254
[No Abstract] [Full Text] [Related]
22. Prolonged survival of class I deficient mouse islet allografts but not xenografts.
Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF
Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641
[No Abstract] [Full Text] [Related]
23. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
24. Tissue immunogenicity: the role of MHC antigen and the lymphocyte costimulator B7-1.
Coulombe M; Yang H; Guerder S; Flavell RA; Lafferty KJ; Gill RG
J Immunol; 1996 Dec; 157(11):4790-5. PubMed ID: 8943380
[TBL] [Abstract][Full Text] [Related]
25. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
26. Xenogeneic but not allogeneic pancreatic islet graft survival in recipients lacking humoral immunity and major histocompatibility complex class II antigens.
Chu G; Markmann JF; Ahn M; Chang E; DeMatteo RP; Ketchum RJ; Brayman KI; Deng S; Barker CF
Transplant Proc; 1997; 29(1-2):901-2. PubMed ID: 9123579
[No Abstract] [Full Text] [Related]
27. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
Reich EP; Sherwin RS; Kanagawa O; Janeway CA
Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
[TBL] [Abstract][Full Text] [Related]
28. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
Ohzato H; Monaco AP
Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
[No Abstract] [Full Text] [Related]
29. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
Coulombe M; Yang H; Wolf LA; Gill RG
J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
[TBL] [Abstract][Full Text] [Related]
30. Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.
Marusić-Galesić S; Walden P
Immunology; 1995 Jul; 85(3):442-6. PubMed ID: 7558133
[TBL] [Abstract][Full Text] [Related]
31. Alloresponses in vitro and in vivo show restricted T-cell receptor V beta gene usage.
Hanto DW; Ruger JK; Rossi SJ
Transplant Proc; 1995 Feb; 27(1):491-3. PubMed ID: 7879073
[TBL] [Abstract][Full Text] [Related]
32. Class I and class II antigens in the rejection of murine islet cell transplants.
Hauptfeld V; Lacy PE; Graff RJ
Transplant Proc; 1995 Dec; 27(6):3234-5. PubMed ID: 8539929
[No Abstract] [Full Text] [Related]
33. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
[TBL] [Abstract][Full Text] [Related]
34. Multiple donor allotransplantation. A new approach to pancreatic islet transplantation.
Gotoh M; Porter J; Kanai T; Monaco AP; Maki T
Transplantation; 1988 Jun; 45(6):1008-12. PubMed ID: 3132760
[TBL] [Abstract][Full Text] [Related]
35. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
36. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
[TBL] [Abstract][Full Text] [Related]
38. MHC class II antigen expression on the various cells of normal and activated isolated pancreatic islets.
Ulrichs K; Müller-Ruchholtz W
Diagn Immunol; 1985; 3(1):47-55. PubMed ID: 3922662
[TBL] [Abstract][Full Text] [Related]
39. Induction of class II major histocompatibility antigens on thyroid, adult pancreatic islet, and fetal proislet allografts.
Warren HS; Hodder MJ; Allan W; Hume DA; Simeonovic CJ
Transplantation; 1992 Apr; 53(4):834-40. PubMed ID: 1566350
[TBL] [Abstract][Full Text] [Related]
40. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
